|
The
growing trend towards public-private interactions and the impact on
public health - 1999
WHO's and other international agencies
and governmental bodies' increasingly close collaboration with the pharmaceutical
industry has caused HAI and a number of public interest organisations
to raise concerns about conflict of interest. HAI has focused attention
on this issue at various fora involving WHO and other agencies.
Developments
22 December 1999
HAI
responds to draft WHO Guidelines on
Interaction with Commercial Enterprises, click
here to see comments by other organisations.
October 1999
HAI invited to comment on draft
WHO Guidelines on Interaction with Commercial Enterprises.
May 1999
At the 52nd World Health Assembly, HAI focused
attention on WHO's increasing dependence on private sector funding in
a letter to WHO's Director General. Below are related items of correspondence
for those following this debate.
Letter
to Dr. Brundtland
NGO
statement in support of HAI's letter
Response
from Dr. Brundtland
|